Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin add-on to metformin XR in adults with type 2 diabetes mellitus
2008-000976-26Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Saxagliptin + metformin XR with Placebo + metformin XR (2 arms). Primary endpoint: Change from baseline to Week 4 in 24-hour mean weighted glucose. Started Jul 2008; status: completed.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-000976-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000976-26.